Oncethe uneligible applications are weeded out, a follow-up group will review the filings and make a recommendation to DKMA. The regulator will then make a recommendation to the Ministry of Health, which has the final say on which of the applications will receive funding. DKMA expects one to two applications to receive government support. DKMA is looking to the successful applicants to add to scientific and regulatory understanding about medicinal uses of cannabis. The projects that generate this understanding could be randomized clinical trials, case-control studies or studies comparing the use of cannabis products to conventional treatments. More Information On RAPS